<--- Back to Details
First PageDocument Content
Foreign relations / Law / Government / Patent law / Compulsory license / Imatinib / Novartis / Doha Declaration / TRIPS Agreement / Pharmaceutical industry / Pharmaceutical drug / Knowledge Ecology International
Date: 2015-08-18 03:24:32
Foreign relations
Law
Government
Patent law
Compulsory license
Imatinib
Novartis
Doha Declaration
TRIPS Agreement
Pharmaceutical industry
Pharmaceutical drug
Knowledge Ecology International

Microsoft Word - 150818_Open Letter CL Glivec Colombia_BD Format

Add to Reading List

Source URL: www.ladb.ch

Download Document from Source Website

File Size: 126,53 KB

Share Document on Facebook

Similar Documents

The dosage is based on RV 8.48 cited above plants as well as any products such as furazolidone , if you are meant to be decreased when these drugs imatinib brands in india is firstly their application for treatment of me

The dosage is based on RV 8.48 cited above plants as well as any products such as furazolidone , if you are meant to be decreased when these drugs imatinib brands in india is firstly their application for treatment of me

DocID: 1sBQT - View Document

Why we focus on Leukaemia Leukaemias can be acute or chronic and arise from the myeloid or lymphoid lineage. The treatment of chronic myeloid leukamia (CML) has been revolutionised by the use of agents such as Imatinib t

Why we focus on Leukaemia Leukaemias can be acute or chronic and arise from the myeloid or lymphoid lineage. The treatment of chronic myeloid leukamia (CML) has been revolutionised by the use of agents such as Imatinib t

DocID: 1rNr7 - View Document

A conserved protonation-dependent switch controls drug binding in the Abl kinase Yibing Shana, Markus A. Seeligerb, Michael P. Eastwooda, Filipp Frankb, Huafeng Xua, Morten Ø. Jensena, Ron O. Drora, John Kuriyanb,1, and

A conserved protonation-dependent switch controls drug binding in the Abl kinase Yibing Shana, Markus A. Seeligerb, Michael P. Eastwooda, Filipp Frankb, Huafeng Xua, Morten Ø. Jensena, Ron O. Drora, John Kuriyanb,1, and

DocID: 1rq9v - View Document

imatinib and colon cancer. imatinib availability imatinib and cml imatinib and tight junction cancer imatinib prostate dercum and imatinib zactima plus imatinib

imatinib and colon cancer. imatinib availability imatinib and cml imatinib and tight junction cancer imatinib prostate dercum and imatinib zactima plus imatinib

DocID: 1rdbp - View Document

Forschung aus erster Hand Healthy Ageing 02  Le i

Forschung aus erster Hand Healthy Ageing 02 Le i

DocID: 1r59K - View Document